ProMIS Neurosciences PMN
NASDAQ PMN
$9.02 -0.11 (-1.20%)
As of: Oct 22, 2026 · 11:51 AM EDT

ProMIS Neurosciences (PMN) Long-Term Debt Issuances (2021)

Updated

ProMIS Neurosciences (PMN) recorded Long-Term Debt Issuances of $6.92 million in FY2021.

Analysis

ProMIS Neurosciences (PMN) Long-Term Debt Issuances (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,171.69 Bn 1,140.28 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 649.22 Bn 569.08 Bn 17.30 Bn -
3 AbbVie 504.17 Bn 477.29 Bn 12.70 Bn -
4 Merck 366.35 Bn 320.73 Bn 12.21 Bn -
5 Novartis Ag 303.54 Bn 267.53 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 269.49 Bn 243.18 Bn 12.86 Bn -
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn -
8 Gilead Sciences 195.09 Bn 169.29 Bn 6.22 Bn -
9 Pfizer 172.48 Bn 119.12 Bn 10.94 Bn -
10 ProMIS Neurosciences 82.46 Mn -56.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 32,668.00
API Access

ProMIS Neurosciences Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=PMN&period=max&api_key=YOUR_API_KEY